Literature DB >> 29723811

Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: A systematic review and meta-analysis.

Padraig Oakley1, Steve Kisely2, Amanda Baxter1, Meredith Harris3, Jocelyne Desoe4, Alyona Dziouba4, Dan Siskind5.   

Abstract

INTRODUCTION: There is increasing evidence of excess mortality in schizophrenia but less information on other non-affective psychoses. We therefore generated standardised mortality ratios (SMRs) for community-dwelling people with schizophrenia and other non-affective psychoses, relative to the general population, and examined changes to the SMR over time.
METHODS: We conducted a systematic review in which Pubmed, CINAHL, EMBASE, Google Scholar and PsycINFO were searched for publications that reported SMRs for all-cause mortality among community-dwelling people with schizophrenia and psychotic disorders. Meta-analyses of SMRs were conducted, pooled across genders and then separately by gender. Sub-group analyses were conducted for diagnostic group, global region, decade and risk of study bias.
RESULTS: We were able to include 34 studies covering 1,724,906 participants. The gender pooled SMR for schizophrenia and psychotic disorders was 3.08 (95%CI 2.88-3.31). Schizophrenia and broader psychotic disorders had similar SMRs. Stratification by decade of observation suggests that the difference in SMR is not declining and may possibly be widening. Analyses showed high levels of heterogeneity.
CONCLUSIONS: The appearance of a static or widening mortality gap over time between people with schizophrenia and psychotic disorders and the general population is of concern. However, whether it is an increase over time is unclear, as there are insufficient studies to confirm this.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mortality; Non-affective psychoses; Schizophrenia

Mesh:

Year:  2018        PMID: 29723811     DOI: 10.1016/j.jpsychires.2018.04.019

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  31 in total

1.  Performance in Practice: Practice Assessment Tool for the Care of Patients With Schizophrenia.

Authors:  Laura J Fochtmann; Jennifer Medicus; Seung-Hee Hong
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

2.  The clinical characterization of the patient with primary psychosis aimed at personalization of management.

Authors:  Mario Maj; Jim van Os; Marc De Hert; Wolfgang Gaebel; Silvana Galderisi; Michael F Green; Sinan Guloksuz; Philip D Harvey; Peter B Jones; Dolores Malaspina; Patrick McGorry; Jouko Miettunen; Robin M Murray; Keith H Nuechterlein; Victor Peralta; Graham Thornicroft; Ruud van Winkel; Joseph Ventura
Journal:  World Psychiatry       Date:  2021-02       Impact factor: 49.548

3.  Antipsychotic utilization patterns in pregnant women with psychotic disorders: a 16-year population-based cohort study.

Authors:  Jenny Wai Yiu Law; Joe Kwun Nam Chan; Corine Sau Man Wong; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-06       Impact factor: 5.270

4.  Association between depression in chronic phase and future clinical outcome of patients with schizophrenia.

Authors:  Yuto Yamada; Yusuke Yamauchi; Shinji Sakamoto; Masaki Fujiwara; Yuko Okahisa; Soshi Takao; Manabu Takaki; Norihito Yamada
Journal:  Psychopharmacology (Berl)       Date:  2022-02-21       Impact factor: 4.530

5.  The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials.

Authors:  Davy Vancampfort; Joseph Firth; Christoph U Correll; Marco Solmi; Dan Siskind; Marc De Hert; Rebekah Carney; Ai Koyanagi; André F Carvalho; Fiona Gaughran; Brendon Stubbs
Journal:  World Psychiatry       Date:  2019-02       Impact factor: 49.548

6.  Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study.

Authors:  Nicholas Chak Lam Yung; Corine Sau Man Wong; Joe Kwun Nam Chan; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

7.  The shared genetic architecture of schizophrenia, bipolar disorder and lifespan.

Authors:  Gerard Muntané; Xavier Farré; Elena Bosch; Lourdes Martorell; Arcadi Navarro; Elisabet Vilella
Journal:  Hum Genet       Date:  2020-08-09       Impact factor: 4.132

8.  Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Psychotic Disorders: A Population-Based Cohort Study.

Authors:  Wing Chung Chang; Joe Kwun Nam Chan; Corine Sau Man Wong; JoJo Siu Han Hai; Philip Chi Fai Or; Eric Yu Hai Chen
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

9.  Switching strategies for antipsychotic monotherapy in schizophrenia: a multi-center cohort study of aripiprazole.

Authors:  Yoshiaki Obayashi; Satoshi Mitsui; Shinji Sakamoto; Nozomu Minao; Bunta Yoshimura; Toshiki Kono; Yuji Yada; Yuko Okahisa; Soshi Takao; Yoshiki Kishi; Toshihiko Takeda; Manabu Takaki; Norihito Yamada
Journal:  Psychopharmacology (Berl)       Date:  2019-10-18       Impact factor: 4.530

10.  Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis.

Authors:  Dan Siskind; Erin Gallagher; Karl Winckel; Samantha Hollingworth; Steve Kisely; Joseph Firth; Christoph U Correll; Wade Marteene
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.